Eric Dube, Ph.D. has served as President and Chief Executive Officer of Travere Therapeutics, Inc. and as a member of Travere’s board of directors since January 2019. Previously, Dr. Dube served as the Head of North America of ViiV Healthcare, and as Sr. Vice President and Head, Global Respiratory Franchise, of GlaxoSmithKline. Dr. Dube served as Senior Vice President, Respiratory Japan of GSK. Earlier in his career, Dr. Dube held positions of increasing responsibility at GSK including senior leadership roles in Strategy, Planning & Operations, Oncology, Managed Markets and Marketing. Dr. Dube currently serves on the Board of Directors for the Biotechnology Innovation Organization (BIO), and for Reneo Pharmaceuticals, Inc. Dr. Dube holds a B.S. from Santa Clara University and a M.A. and Ph.D. from Cornell University.